{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:18:40Z","timestamp":1759011520815},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.diagmicrobio.2011.02.009","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T18:44:42Z","timestamp":1308941082000},"page":"373-379","source":"Crossref","is-referenced-by-count":16,"title":["Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance"],"prefix":"10.1016","volume":"70","author":[{"given":"Juan J.","family":"Picazo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Betriu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iciar","family":"Rodr\u00edguez-Avial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Culebras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"L\u00f3pez-Fabal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.diagmicrobio.2008.01.012","article-title":"In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates","volume":"61","author":"Anastasiou","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.diagmicrobio.2007.11.002","article-title":"Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus","volume":"60","author":"Bennett","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2007.03.015","article-title":"Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003\u20132004)","volume":"30","author":"Biedenbach","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0020","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/AAC.00719-06","article-title":"Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci","volume":"51","author":"Bourgeois","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.diagmicrobio.2008.01.019","article-title":"In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes","volume":"61","author":"Campanile","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0030","series-title":"Performance standards for antimicrobial susceptibility testing. 20th informational supplement. vol. 30, no. 1, M100-S20","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2010"},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0035","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 8th ed. vol 29, no. 2. M7-A8","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009"},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0040","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/JCM.02098-09","article-title":"Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative staphylococci isolated from orthopedic-device-associated infections","volume":"48","author":"Cremniter","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0045","author":"Cubicin Package Insert"},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0050","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0055","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1086\/596630","article-title":"Vancomycin heteroresistance and methicillin-resistant Staphylococcus aureus","volume":"199","author":"Deresinski","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/AAC.00945-07","article-title":"Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006","volume":"52","author":"Holmes","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0065","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijantimicag.2008.05.007","article-title":"Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections","volume":"32","author":"Hsu","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Suppl. 1","key":"10.1016\/j.diagmicrobio.2011.02.009_bb0070","first-page":"513","article-title":"Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal\/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains","volume":"42","author":"Jones","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0075","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1128\/AAC.50.4.1156-1163.2006","article-title":"Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates","volume":"50","author":"Kehrenberg","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/dkn520","article-title":"Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides","volume":"63","author":"Leonard","year":"2009","journal-title":"J. Antmicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0085","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijantimicag.2005.01.015","article-title":"Rapid increase in numbers of Staphylococcus epidermidis strains with reduced susceptibility to teicoplanin in Greece","volume":"25","author":"Maniati","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0095","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/596629","article-title":"Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia","volume":"199","author":"Maor","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0100","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1128\/JCM.00407-09","article-title":"Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005","volume":"47","author":"Mason","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jac\/42.2.189","article-title":"Glycopeptide tolerance in Staphylococcus aureus","volume":"42","author":"May","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1086\/650574","article-title":"Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus","volume":"50","author":"Morales","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0115","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/JCM.02135-08","article-title":"Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years","volume":"47","author":"Musta","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0120","series-title":"Methods for determining bactericidal activity of antimicrobial agents. Approved standard M26-A","author":"National Committee for Clinical Laboratory Standards","year":"1999"},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0125","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/JCM.01182-10","article-title":"Vancomycin MIC for methicillin-resistant coagulase-negative Staphylococcus sp.: Evaluation of the broth microdilution and Etest methods","volume":"48","author":"Paiva","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/44.1.121","article-title":"Glycopeptide tolerance in bacteria causing endocarditis","volume":"44","author":"Perry","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0135","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2006.10.007","article-title":"Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005)","volume":"57","author":"Pfaller","year":"2007","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0140","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.diagmicrobio.2009.03.020","article-title":"Activity of daptomycin against staphylococci collected from bloodstream infections in Spanish medical centers","volume":"64","author":"Picazo","year":"2009","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0145","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1157\/13095373","article-title":"Vigilancia de resistencias a los antimicrobianos: estudio VIRA 2006","volume":"24","author":"Picazo","year":"2006","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/JCM.00914-10","article-title":"Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in clinical methicillin-resistant S. aureus (MRSA) Isolates","volume":"49","author":"Pitz","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0155","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/AAC.00904-08","article-title":"Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used","volume":"52","author":"Prakash","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0160","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.diagmicrobio.2009.09.017","article-title":"Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 \u03bcg\/mL isolated in the United States and European hospitals (2006\u20132008)","volume":"66","author":"Sader","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0165","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.diagmicrobio.2009.06.016","article-title":"Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007\u20132008)","volume":"65","author":"Sader","year":"2009","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0170","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1179\/joc.2009.21.5.500","article-title":"Update on the in vitro activity of daptomycin tested against 17,193 Gram-positive bacteria isolated from European medical centers (2005\u20132007)","volume":"21","author":"Sader","year":"2009","journal-title":"J. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0175","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0185","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001\u20132005","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0190","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1128\/AAC.01022-08","article-title":"Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007","volume":"53","author":"Traczewski","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0195","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/JCM.44.5.1922-1923.2006","article-title":"High prevalence of teicoplanin resistance among Staphylococcus epidermidis strains in a 5-year retrospective study","volume":"44","author":"Trueba","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0200","first-page":"302","article-title":"Performance of various testing methodologies for detection of heteroresistant vancomycin intermediate Staphylococcus aureus (hVISA) in bloodstream isolates","volume":"02","author":"van Hal","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.02.009_bb0205","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/JCM.01388-06","article-title":"Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period","volume":"44","author":"Wang","year":"2006","journal-title":"J. Clin. Microbiol."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889311000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889311000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T20:21:32Z","timestamp":1543695692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889311000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0732889311000873"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2011.02.009","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}